Andrew Clay

Andrew Clay is a Scientist at Aktis Oncology, with prior experience as a Senior Research Associate and Research Associate at Kronos Bio, Inc. Andrew also worked as a Scientist at Eccrine Systems, Inc. Andrew holds a Master of Science in Chemistry and a Bachelor of Science in Chemistry, both from Georgia State University.